Navigation Links
ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
Date:11/20/2007

TORONTO, Nov. 20 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that Daniel S. Pereira, Ph.D., Vice President of Research, will present at the 14th Annual BioNorth Biotechnology and Life Sciences Conference. Dr. Pereira will present on ARIUS' non-traditional approach to drug discovery using its proprietary FunctionFIRST(TM) technology.

The conference is being held at the Ottawa Congress Centre in Ottawa, Ontario and ARIUS' presentation is scheduled for Tuesday, November 20th at 10:30am EST in Capital Hall 1B. Additional information about the 14th Annual BioNorth Biotechnology and Life Sciences Conference can be found at: http://www.bionorth.ca

About ARIUS

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 500 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusmabs.com

Forward-Looking Statements

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
2. ARIUS Announces Third Quarter Fiscal 2007 Financial Results
3. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
4. ARIUS to present at Chinese Global Financial Forum
5. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
6. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
7. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
8. Avicena Group to Present at Noble Financial Conference
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... (Nasdaq: VIAP ), a biotechnology company focused on ... and metabolic disease, today announced that it has completed ... clinical trial of VIA-2291. ,, The FDG-PET trial ... sites in the US and Canada including Massachusetts General ...
(Date:12/3/2009)... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that ... of fiscal year 2010 on December 10, 2009 at 7:00 ... to discuss the results at 11:30 a.m. EST on the ... for the second quarter ended October 31, 2009 and will ...
(Date:12/3/2009)... Sciences, Inc. (Nasdaq: CALP ), a leading provider ... sciences research, today introduced Living Image 4.0 software for ... the more than 800 Caliper IVIS systems currently installed ... unmixing tools to enhance fluorescent sensitivity and automated 3D ...
(Date:12/2/2009)... MATK ) announced today that it intends to release ... on December 16, 2009, at approximately 4:00 p.m. Eastern Time ... will conduct a conference call to discuss these results with ... live via webcast by visiting Martek,s web site at ...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2
... MOUNTAIN VIEW, Calif., May 13 Based on ... & Sullivan recognizes Precision Biosciences with the 2009 ... Innovation of the Year. The company,s radical Directed ... and modify regions of a cell,s genome with ...
... 12 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) ... on Tuesday, May 19, 2009 at 11:30 a.m. ... Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will ... be webcast, and a recording will be made available following ...
... 12 Masimo Corporation (Nasdaq: MASI ), the ... oximetry, today announced that its management is scheduled to present ... Boston, Massachusetts, on Tuesday, May 19, 2009, at 2:35 p.m. ... available on the Masimo website at www.masimo.com . ...
Other Biology Technology:Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market 2Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market 3Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market 4Masimo to Present at the Deutsche Bank 34th Annual Health Care Conference 2
(Date:12/4/2009)... activity in organs relevant for coronary artery disease (CAD), ... identified a module of genes that is important for ... plaque. The findings, which are to be published in ... targeting the migration of white blood cells in the ...
(Date:12/4/2009)... Using a new mathematical model of heart cells, University ... critical enzyme, calmodulin kinase II (CaM kinase), disrupts the ... study, which also involved Columbia University, was published online ... . , "Recently, researchers have developed great interest ...
(Date:12/3/2009)... changes in our daily environment, as well as to retain ... nerve cells communicate, according to a new study by NYU ... week in the journal Nature . , The ... and neuroscience at NYU School of Medicine, discovered that a ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 1PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 2PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 3PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 4Lubris Biomodels Report on Potential New Therapy for Osteoarthritis 14521 1Lubris Biomodels Report on Potential New Therapy for Osteoarthritis 14521 2NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 1NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 2NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 3
... you make for your child could well be a ring ... help the plant produce cyanide to protect itself against ... clover. Other clover plants that do not make cyanide are ... poison, er, clover, ecology and geography play important roles. ...
... pretzel factory production line, with conveyer belts carrying the dough, formed ... , Now imagine what would happen if pretzel dough started to ... misshapen, and sticking fast to the dough of the other fully ... could no longer be conveyed into the oven, the backup of ...
... p.m. , The New York Academy of Sciences, 7 ... York, NY 10007 , The Malaria Research Institute at ... The New York Academy of Sciences present Progress Against ... highlight the latest research developments in the fight to ...
Other Biology News:Genetic differences in clover make one type toxic 2Genetic differences in clover make one type toxic 3Botched production of insulin molecule may lead to diabetes 2Botched production of insulin molecule may lead to diabetes 3Botched production of insulin molecule may lead to diabetes 4Progress Against Malaria: Developments on the Horizon 2